title: [Cardiology update in 2015].
abstract: The present review provides a selected choice of clinical trials and therapeutic advances in the field of cardiology in 2015. A new treatment option in heart failure will become available this year in Switzerland. In interventional cardiology, new trials have been published on the duration of dual antiplatelet therapy, the new stents with bioresorbable scaffold and the long-term results of TAVR in patients who are not surgical candidates or at high surgical risk. RegardingAF the BRIDGE trial provides new evidences to guide the management of patients during warfarin interruption for surgery. Recent publications are changing the paradigm of AF treatment by showing a major impact of the management of cardiometabolic risk factors. Finally, refined criteria for ECG interpretation in athletes have been recently proposed to reduce the burden of false-positive screening.
authors.forename: Patrizio
authors.initials: P
authors.lastname: Pascale
authors.forename: Julien
authors.initials: J
authors.lastname: Regamey
authors.forename: Juan F
authors.initials: JF
authors.lastname: Iglesias
authors.forename: Vincent
authors.initials: V
authors.lastname: Gabus
authors.forename: Mathieu
authors.initials: M
authors.lastname: Clair
authors.forename: Patrick
authors.initials: P
authors.lastname: Yerly
authors.forename: Roger
authors.initials: R
authors.lastname: Hullin
authors.forename: Olivier
authors.initials: O
authors.lastname: Müller
authors.forename: Éric
authors.initials: É
authors.lastname: Eeckhout
authors.forename: Pierre
authors.initials: P
authors.lastname: Vogt
mesh_terms: D002318:Cardiovascular Diseases / Q000628:therapy*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D013557:Switzerland